Company logo

ONCS - OncoSec Medical Incorporated

NASDAQ -> Healthcare -> Biotechnology
Pennington, United States

ONCS price evolution
ONCS
(in millions $) 31 Aug 2021 29 May 2021 31 Mar 2021 31 Dec 2020
Current assets
Cash $45.95 $54.39 $54.39 $60.33
Short term investments
Net receivables
Inventory
Total current assets $49.18 $56.24 $56.24 $62.6
Long term investments
Property, plant & equipment $0.93 $0.93 $6.59 $6.59
Goodwill & intangible assets $0.45 $0.47 $0.48
Total noncurrent assets $7.1 $7.39 $7.39 $7.4
Total investments
Total assets $56.28 $63.63 $63.63 $70.01
Current liabilities
Accounts payable $5.56 $4.67 $4.67 $8.85
Deferred revenue
Short long term debt $2.08 $0.82 $1.58
Total current liabilities $7.96 $5.73 $5.73 $10.8
Long term debt $5.24 $5.49 $6.06
Total noncurrent liabilities $10.24 $10.49 $10.49 $11.06
Total debt $7.32 $6.31 $7.64
Total liabilities $18.2 $16.22 $16.22 $21.86
Shareholders' equity
Retained earnings -$251.78 -$239.98 -$239.98 -$230.54
Other shareholder equity $3.51 $3.32 -$0.36 -$0.29
Total shareholder equity $38.08 $47.41 $48.14
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Current assets
Cash $45.95 $20.35 $25.15 $3.8
Short term investments $23.17
Net receivables
Inventory
Total current assets $49.18 $22.82 $28.51 $28.62
Long term investments
Property, plant & equipment $6.37 $6.76 $1.03 $1.27
Goodwill & intangible assets $0.45
Total noncurrent assets $7.1 $7.08 $1.38 $1.62
Total investments $23.17
Total assets $56.28 $29.9 $29.89 $30.25
Current liabilities
Accounts payable $5.56 $7.92 $4.22 $4.78
Deferred revenue
Short long term debt $2.08 $1.47 $0.08
Total current liabilities $7.96 $9.68 $4.98 $5.85
Long term debt $5.24 $6.35
Total noncurrent liabilities $10.24 $6.35 $0.64 $1.47
Total debt $7.32 $7.82 $0.08
Total liabilities $18.2 $16.03 $5.61 $7.32
Shareholders' equity
Retained earnings -$251.78 -$206.61 -$164.36 -$134.08
Other shareholder equity -$0.08 -$0.02 $0.17 -$0.02
Total shareholder equity $38.08 $13.87 $24.28 $22.92
(in millions $) 31 Aug 2021 29 May 2021 31 Mar 2021 31 Dec 2020
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $7.59 $8.92
Selling, general & administrative $2.85 $2.11
Total operating expenses $13.88 $10.44 $10.44 $11.03
Operating income -$13.88 -$10.44 -$10.44 -$11.03
Income from continuing operations
EBIT -$9.44 -$10.7
Income tax expense -$2.42 $0 $0 $0
Interest expense $0 $0 $0 $0
Net income
Net income -$11.8 -$9.44 -$9.44 -$10.7
Income (for common shares) -$9.44 -$10.7
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $34.1 $25.1 $18.45 $17.42
Selling, general & administrative $14.28 $18.31 $11.97 $18.69
Total operating expenses $48.38 $43.22 $29.98 $36.67
Operating income -$48.38 -$43.22 -$29.98 -$36.67
Income from continuing operations
EBIT -$47.56 -$43.12 -$30.27 -$39.14
Income tax expense -$2.41 -$0.87 $0 $0
Interest expense $0.02 $0.01 $0
Net income
Net income -$45.17 -$42.25 -$30.28 -$39.14
Income (for common shares) -$45.17 -$42.25 -$30.28 -$39.14
(in millions $) 31 Aug 2021 29 May 2021 31 Mar 2021 31 Dec 2020
Net income -$45.17 -$33.37 -$9.44 -$10.7
Operating activities
Depreciation $0.27 $0.27
Business acquisitions & disposals
Stock-based compensation $0.97 $0.61
Total cash flows from operations -$41.79 -$33.39 -$12.8 -$10.85
Investing activities
Capital expenditures -$0.26
Investments
Total cash flows from investing -$0.8 -$0.75 -$0.5
Financing activities
Dividends paid
Sale and purchase of stock $7.81 $45.34
Net borrowings -$0.17 -$0.17
Total cash flows from financing $68.21 $68.2 $7.37 $47.45
Effect of exchange rate -$0.02 -$0.02 -$0 $0.01
Change in cash and equivalents $25.6 $34.04 -$5.94 $36.35
(in millions $) 31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net income -$45.17 -$42.25 -$30.28 -$39.14
Operating activities
Depreciation $1.08 $0.99 $0.24 $0.33
Business acquisitions & disposals
Stock-based compensation $5.6 $4.45 $4.35 $10.1
Total cash flows from operations -$41.79 -$33.15 -$29 -$23.22
Investing activities
Capital expenditures -$0.3 -$0.01 -$0.07
Investments $23.21 -$23.22
Total cash flows from investing -$0.8 $23.2 -$23.29
Financing activities
Dividends paid
Sale and purchase of stock $68.28 $29.98 $28.49 $32.64
Net borrowings -$0.62 $0.81 -$0.08
Total cash flows from financing $68.21 $28.4 $27.2 $38.88
Effect of exchange rate -$0.02 -$0.05 -$0.05 -$0.01
Change in cash and equivalents $25.6 -$4.79 $21.34 -$7.64
Fundamentals
Market cap $47.83M
Enterprise value N/A
Shares outstanding 39.20M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income -$41.38M
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio -1.16
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share 1.17
EPS -$1.06
ROA -65.29%
ROE N/A
Debt/Equity 0.48
Net debt/EBITDA N/A
Current ratio 6.18
Quick ratio N/A